TRDA
Entrada Therapeutics, Inc. · Healthcare
COO Nathan J Dowden sold $65K of Entrada Therapeutics, Inc.
Sold$64,878
$15.11Price
4,293Shares
−6%Stake
What TRDA did after the filing
- The stock from Mon, Sep 26 open, $15.78
- +25.7%
- S&P 500, same days
- +3.7%
Measured over 30 trading days, to the Nov 7 close.
Traded Wed, Sep 21. Filed Fri, Sep 23, 4:55 PM ET, after the close. Returns use the Sep 26 open and the Nov 7 close. Not investment advice.